EquityBulls

Latest News

Diamond Power Infrastructure Ltd secures conductor supply order of Rs. 185 Crore from Adani Energy Solutions Ltd
GRE Renew Enertech Ltd receives orders worth Rs. 23.99 crores
Atishay Limited awarded order worth Rs. 49.35 lakhs
Ajmera Realty Q1 FY27 Operations: Sales Value Surges 35% to ₹146 Crore Powered by Strong Portfolio Realizations
CEAT Ltd - Q1 FY26-27 Consolidated Revenue Rs. 4,318 crore, up 22 % Y-o-Y

Keywords Selected: Tablets

Stock Report

Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
Lupin Launches Azilsartan Medoxomil Tablets in the United States
Dr. Reddy's announces the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States
Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Levothyroxine Sodium Tablets USP
Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
Unichem Pharmaceuticals (USA) Issues Voluntary Recall of Buspirone Hydrochloride Tablets
Lupin Launches Dapagliflozin Tablets in the United States
Lupin announces approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma Ltd receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
Aurobindo Pharma receives USFDA Approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
Lupin Announces the Approval of Dapagliflozin Tablets in the United States
Aurobindo Pharma receives USFDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg
Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets
Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
Eugia Pharma receives USFDA Approval for Everolimus Tablets
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg
Zydus receives final approval from USFDA for Bosentan tablets for oral suspension, 32 mg